Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway
Abstract Hepatocellular carcinoma (HCC) still presents poor prognosis with high mortality rate, despite of the improvement in the management. The challenge for precision treatment was due to the fact that little targeted therapeutics are available for HCC. Recent studies show that metabolic and circ...
Guardado en:
Autores principales: | Cheng Fang, Wenhui Li, Ruozhe Yin, Donglie Zhu, Xing Liu, Huihui Wu, Qingqiang Wang, Wenwen Wang, Quan Bai, Biliang Chen, Xuebiao Yao, Yong Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ff30b6042fd422ea9764d949ca96111 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
por: Greta Garrido, et al.
Publicado: (2019) -
Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
por: Hanneke van Zoggel, et al.
Publicado: (2012) -
The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
por: Wenfeng Liu, et al.
Publicado: (2021) -
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy
por: Eric J. Hsu, et al.
Publicado: (2021) -
Serum Gamma-Glutamyltransferase Levels Predict the Development of Cerebral Infarction in the Korean Population
por: Lee SM, et al.
Publicado: (2021)